NCT06144372

Brief Summary

To evaluate the efficacy and safety of electroconductive (EC) and electrohydraulic (EH) extracorporeal shock wave lithotripsy (ESWL) for the treatment of ureter and kidney stones, this study conducted a randomized controlled trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 31, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 9, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 22, 2023

Completed
Last Updated

November 22, 2023

Status Verified

November 1, 2023

Enrollment Period

1.1 years

First QC Date

November 9, 2023

Last Update Submit

November 20, 2023

Conditions

Keywords

Extracorporeal shockwave lithotripsyUrolithiasisRadiation Exposure

Outcome Measures

Primary Outcomes (32)

  • age

    patient's records

    2 weeks

  • Gender

    patient's records

    2 weeks

  • height

    meters

    2 weeks

  • weight

    kilograms

    2 weeks

  • smoking

    patient's records

    2 weeks

  • drinking

    patient's records

    2 weeks

  • Diabetes mellitus

    patient's records

    2 weeks

  • Hypertension

    patient's records

    2 weeks

  • Preoperative Double J stent

    patient's records

    2 weeks

  • creatinine

    patient's records

    2 weeks

  • Glomerular Filtration Rate

    patient's records

    2 weeks

  • hemoglobin

    patient's records

    2 weeks

  • Hydronephrosis grade

    * Grade 0 : Normal examination with no dilation of the renal pelvis * Grade 1 : Mild dilation of the renal pelvis only * Grade II : Moderate dilation of the renal pelvis including a few calyces * Grade III : Dilation of the renal pelvis with visualization of all the calyces, which are uniformly dilated, and normal renal parenchyma * Grade IV : Similar apperance of the renal pelvis and calyces as Grade III, plus thinning of the renal parenchyma

    2 weeks

  • Analgesic

    patient's records

    2 weeks

  • stone size

    patient's records

    2 weeks

  • Stone laterality

    patient's records

    2 weeks

  • Stone location

    patient's records

    2 weeks

  • Stone volume

    patient's records

    2 weeks

  • Stone shape

    patient's records

    2 weeks

  • Stone to skin distance

    patient's records

    2 weeks

  • Hounsfield unit

    patient's records

    2 weeks

  • Urine color

    patient's records

    2 weeks

  • Urine Turbidity

    patient's records

    2 weeks

  • Urine Specific Gravity

    patient's records

    2 weeks

  • Urine pH

    patient's records

    2 weeks

  • Intensity

    ESWL

    2 weeks

  • Used power

    ESWL

    2 weeks

  • Shock

    ESWL

    2 weeks

  • Speed

    ESWL

    2 weeks

  • Visual analog scale for pain

    0: Represents "No sensation" or "Not at all." 1-3: Indicates a very mild sensation or a low level of the experience, signifying almost no problem. 4-6: Represents a moderate level, suggesting a moderate presence of the experience or issue. 7-9: Reflects a high or severe level, signifying a significant presence or seriousness of the problem. 10: Represents "Maximal sensation" or "Extremely intense" and indicates an extreme presence or severity of the experience or issue.

    2 weeks

  • Satisfaction score

    1. Not satisfied at all. 2. Very low satisfaction. 3. Moderate satisfaction. 4. High satisfaction. 5. Very high or maximum satisfaction.

    2 weeks

  • Stone-free rates (%)

    ESWL

    2 weeks

Study Arms (2)

Electroconductive Type

OTHER

Sonolith i-move® shockwave lithotripter (EDAP, Lyon, France)

Device: Electroconductive and Electrohydraulic types

Electrohydraulic Type

OTHER

Rifle lithotripter (HNT Medical, Seoul, Korea)

Device: Electroconductive and Electrohydraulic types

Interventions

The patients were randomly assigned to two types of lithotripter.

Electroconductive TypeElectrohydraulic Type

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • The analysis included cases of stones in the upper kidney and ureter, with diameters ranging from 5 mm to 15 mm.

You may not qualify if:

  • Patients with musculoskeletal deformities, ongoing urinary tract infections requiring prioritized infection treatment, blood clotting disorders, and ureteral obstruction that made stone expulsion difficult were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 110-744, South Korea

Location

Related Publications (1)

  • Motolova M, Kral M. Effect of targeting and generator type on efficacy of extracorporeal shock wave lithotripsy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Dec;166(4):434-440. doi: 10.5507/bp.2022.029. Epub 2022 Jun 27.

    PMID: 35801399BACKGROUND

MeSH Terms

Conditions

Urolithiasis

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

November 9, 2023

First Posted

November 22, 2023

Study Start

March 31, 2022

Primary Completion

May 16, 2023

Study Completion

May 16, 2023

Last Updated

November 22, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

The datasets used during the current study are available from the corresponding author on request.

Locations